Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
Help ACP better understand safety culture in pharmacy
December 2, 2025
We’re listening! Share your experiences with us.
Read more ➞